Industries de la santé
FDNA and CENTOGENE Announce First Grant of Molecular Testing Under the Face2Gene Unknown Forum Grant Program at the American Society of Human Genetics (ASHG) Annual Meeting
18 Octobre 2016
Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics, enabled the first grant of molecular testing for a patient with an unknown genetic disorder. The collaboration extends beyond financial support and includes the successful integration of Face2Gene LABS API with CENTOGENE’s bioinformatics pipeline to improve variant... |Plus d'articles...
- US to lose dominance of global generics market as emerging economies take over, says GBI Research survey
- ABIVAX : Publication d'une lettre aux actionnaires
- Pharnext soutient la première conférence dédiée aux patientsatteints de la maladie de Charcot-Marie-Tooth organisée par l'association Hereditary Neuropathy Fondation
- Percutaneous coronary interventions market will grow steadily to surpass $8 billion by 2022, says GlobalData